Back

Great Safety and Efficacy of a New Drug-eluting-stent manufactured in a developing country at minimal cost: The VSTENT at 3 years follow-up

26 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: Long-term PCI outcomes Devices ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Thuan Nguyen Van

Ho Chi Minh City (Viet Nam)

5 More presentations in this session

Presentation thumbnail
Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial
Doctor S. KAGEYAMA (Shizuoka, JP)
Abstract Slides
Presentation thumbnail
Comparison of outcomes between a single long stent and overlapping stents in long coronary artery lesion: a meta-analysis of the current literature
Associate Professor T. Cinar (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Impact of left ventricular ejection fraction on 10-year mortality after percutaneous coronary intervention or coronary artery bypass grafting
Doctor S. Masuda (Galway, IE)
Abstract Slides
Presentation thumbnail
Ten-year trends of clinical outcomes after percutaneous coronary intervention
Professor J. Choi (Seoul, KR)
Abstract Slides
Presentation thumbnail
Impact of body mass index on outcomes in patients undergoing percutaneous coronary intervention for in-stent restenosis
Doctor A. Spirito (Lucerne, CH)
Abstract Slides

Access the full session

Session thumbnail
Long-term PCI outcomes

The Event

Event poster

ESC Congress 2022

26 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Session
Complex device therapy
thumbnail
Congress Session
Lead extraction
thumbnail
Congress Session
PCI complications: the lyrics from my worst nightmares

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources